Medical aesthetics company Cynosure said on Tuesday that it has received US Food and Drug Administration (FDA) approval of the first and only four-mode RF microneedling device Potenza radiofrequency (RF) microneedling for electrocoagulation and hemostasis of soft tissue for dermatologic conditions.

Under the Potenza device's four modes, the monopolar RF mode delivers energy across a large area of tissue for deep heating and skin tightening through soft tissue coagulation, not only on the face, but anywhere on the body, while the bipolar RF mode offers more concentrated delivery of energy to treat superficial tissue and provide ideal skin revitalization results, added the company.

Together, the Potenza device's four modes offer more customized microneedling treatments for patients and allow practitioners to deliver both shallow and deep treatments on a single system, according to the company.

The groundbreaking device is equipped with Tiger Tip technology, the first semi-insulated needles of its design that allow practitioners to expand the treatment zone and address more tissue per treatment, which translates to quicker sessions for patients, without sacrificing the epidermis. The device is armed with a single-needle handpiece designed to target and improve blemishes, concluded the company.